Cargando…

Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells

Detalles Bibliográficos
Autores principales: Simko, Fedor, Baka, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832014/
https://www.ncbi.nlm.nih.gov/pubmed/35153802
http://dx.doi.org/10.3389/fphar.2022.842512
_version_ 1784648635130052608
author Simko, Fedor
Baka, Tomas
author_facet Simko, Fedor
Baka, Tomas
author_sort Simko, Fedor
collection PubMed
description
format Online
Article
Text
id pubmed-8832014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88320142022-02-12 Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells Simko, Fedor Baka, Tomas Front Pharmacol Pharmacology Frontiers Media S.A. 2022-01-28 /pmc/articles/PMC8832014/ /pubmed/35153802 http://dx.doi.org/10.3389/fphar.2022.842512 Text en Copyright © 2022 Simko and Baka. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Simko, Fedor
Baka, Tomas
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
title Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
title_full Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
title_fullStr Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
title_full_unstemmed Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
title_short Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
title_sort commentary: effect of angiotensin-converting-enzyme inhibitor and angiotensin ii receptor antagonist treatment on ace2 expression and sars-cov-2 replication in primary airway epithelial cells
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832014/
https://www.ncbi.nlm.nih.gov/pubmed/35153802
http://dx.doi.org/10.3389/fphar.2022.842512
work_keys_str_mv AT simkofedor commentaryeffectofangiotensinconvertingenzymeinhibitorandangiotensiniireceptorantagonisttreatmentonace2expressionandsarscov2replicationinprimaryairwayepithelialcells
AT bakatomas commentaryeffectofangiotensinconvertingenzymeinhibitorandangiotensiniireceptorantagonisttreatmentonace2expressionandsarscov2replicationinprimaryairwayepithelialcells